Stay updated on SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial
Sign up to get notified when there's something new on the SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial page.

Latest updates to the SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial page
- CheckyesterdayChange DetectedA sitewide NIH notice was added, announcing updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check8 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedThe site revision label in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error for the study record, preventing access to the study details. The header and footer are visible, but the main content is unavailable.SummaryDifference18%

- Check56 days agoChange DetectedThe page Revision tag has been updated from v3.6.5 to v3.6.6, indicating a new build of the page. No changes to the study content or data are indicated by this update.SummaryDifference0.1%

- Check71 days agoChange DetectedNew navigation and metadata entries were added to the page, including FDA-regulated product indicators and related MeSH terms. Footer and helper section labels were expanded to provide more contextual information.SummaryDifference48%

Stay in the know with updates to SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SCR-6920 Capsule Safety in Malignant Tumors Clinical Trial page.